Additional cuts to Medicare Advantage plans would unduly affect the more than one-third of beneficiaries in the low-income bracket, according to a report from America's Health Insurance Plans.
Medicare Advantage is crucially important to beneficiaries with low income, according to a new report from America’s Health Insurance Plans (AHIP). If additional cuts were to be introduced to the program, more than one-third of Medicare Advantage beneficiaries in the low-income bracket would be unduly affected.
The report points out that more than 37% of Medicare Advantage beneficiaries fall in the low-income category with incomes below $20,000. Across the country, 17 million seniors—roughly 30% of all Medicare enrollees in 2015—have chosen Medicare Advantage for the higher quality care and additional benefits these plans provide.
Findings of the Report
Unlike traditional fee-for-service Medicare, Medicare Advantage offers far-reaching disease management programs and care coordination services to help millions of seniors deal with their health conditions. These programs are critically important for low-income beneficiaries, as they are more likely to have multiple chronic diseases.
The report used data from the 2013 Medicare Current Beneficiary Survey maintained by CMS. Non-institutionalized beneficiaries eligible for Medicare as of January 1, 2013, were interviewed from all 50 states, the District of Columbia, and Puerto Rico. AHIP found that:
Conclusion
Medicare Advantage remains critically important for beneficiaries of diverse origins as well as the low-income levels. Research has repeatedly shown that these Medicare Advantage programs have significantly improved health outcomes for seniors. If the payment policies were to be changed, it would further impact the coverage and benefit options for such beneficiaries.
"For our nation's seniors and the most vulnerable citizens, Medicare Advantage's comprehensive, coordinated approach to care delivery improves beneficiaries' health and quality of life," AHIP President and CEO Marilyn Tavenner said.
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More